I-Lysobact ibhekwa njengeyasebenza kakhulu, kepha iphikisana nabantu abane-lactose ukungabekezelelani, futhi ngaphandle kwalokho, ayiniki umphumela osheshayo.
Yini engayenza esikhundleni se-Lizobakt?
Ukunquma ukuthi yisiphi isidakamizwa sokuthi sithathe indawo ye-Lysobact, kufanele sikhumbule ukuthi izifanekiselo zingaba isakhiwo (sinomzimba osebenzayo), futhi ngomphumela (onomthelela ofanayo wokwelapha, kodwa ngokusekelwe kwezinye izinto).
Izinto ezisebenzayo e-Lizobakt yi-lysozyme ne-pyridoxine. Ama-analogues aphelele ekubunjweni kwemisebenzi esebenzayo le mithi ayinayo, kodwa isimo se-Lizobakt esakhiweni esakhiweni sihlanganisa uLaripront noHexalysis, ehlanganisa i-lysozyme.
Ngokusho kwesenzo samakhemikhali (ama-antiseptic kanye nama-immunomodulating agents) uhlu lwabalinganiswayo lukhulu kakhulu, futhi lungabizwa ngokuthi i-Imudon (immunomodulator) kanye nezidakamizwa ezinjalo noma izidakamizwa zokulwa namagciwane njenge:
- Tharyngept;
- Inhaliptus ;
- Sebidine;
- Hexoral;
- Rince Lorcept;
- I-Strepsils;
- Gramdin nabanye.
Izinzuzo nezimo ezimbi ze-Lizobakt analogues
Cabanga ngokufaka endaweni ethandwa kakhulu kwe-Lysobact, futhi yiziphi izimo ezisetshenziswa kakhulu.
Yini engcono - i-Lizobakt noma i-Laripront?
Zombili izidakamizwa zine-lysozyme. Ukwakhiwa kwe-lysobacter kufaka phakathi i-pyridoxine (i-analogue yokwenziwa kwe-vitamin B6), enomphumela wokuzivikela ekwenzeni i-mucosa futhi ikhulise umkhuhlane. Ekubunjweni kweLaripronta kukhona i-dekvalinia chloride - isifo sokulwa nesifo sokulwa nesifo sokulwa nesifo somzimba esine-anti-bacterial. I-Laripont inezimpikiswano ezithinta kakhulu, kodwa ayithinti ukuvuselelwa kwe-mucosa, futhi ibiza okungaphezulu kuka-Lizobakt.
Yikuphi okungcono - i-Lizobakt noma i-Hexaliz?
Ekubunjweni kweHexalysis, ngaphezu kwe-lysozyme, kufaka i-biclutymol ne-enoxolone. Isidakamizwa sinomthelela omkhulu wokulwa nokuvuvukala, we-antiviral kanye ne-antimicrobial. Inqunywe udokotela kuphela enezinkomba ezicacile futhi azihlanganisiwe namanye amalungiselelo angokwezihloko. Kuyabiza kakhulu kuneLizbakt.
Yini engcono - i-Lizobakt noma i-Imudon?
I-Imudon ikulungiselela ngokuzenzakalela imithwalo yemiphumela yendawo. Ukwandisa ukukhiqizwa kwe-interferon, i-lysozyme, i-immunoglobulin A ematheni futhi kukhulise ukwanda kwenani lama-phagocytes (amangqamuzana omzimba omzimba). Umphumela wesidakamizwa awusizo ngokushesha, ngakho-ke awunawo umphumela we-antiseptic, ngakho-ke, ngokuvuvukala komlomo nomlomo, kunconywa ukuba i-Imudon ingasetshenziswanga esikhundleni, kepha ihlanganiswe nama-antiseptic agents.
Okungcono - Tharyngept noma Lizobakt?
I-Farnigosept yi-antiseptic yokuchayeka kwendawo ngesisekelo se-Ambasone. Unomthelela onamandla we-bacteriostatic (ikhono lokuvimbela ukukhiqizwa kwama-bacteria), ikakhulukazi maqondana ne-pneumococci ne-streptococci. I-Farnigosept ivame ukusetshenziselwa ukutheleleka kwepheshana eliphezulu lokuphefumula, ngoba kulokhu umphumela wayo ubonakala kakhulu. Ezokwelapha amazinyo kuphumelela kakhulu
Okungcono - Grammidine noma Lizobakt?
I-Gramidine iyi-antibiotic ephumelelayo ngokumelene nawo wonke amagciwane adala ukuvuvukala komlomo nomphimbo. Isetshenziselwa i-angina, i-acry pharyngitis, i-tonsillitis, i-stomatitis, i-periodontitis, i-gingivitis. Njenganoma iyiphi imithi elwa namagciwane, ingaba nomthelela omkhulu esimweni se-microflora yonke, hhayi nje kuphela i-pathogenic. Ngakho-ke, lisetshenzisiwe uma ama-antiseptic efana ne-Lysobact engasebenzi, noma ehlangene nawo, ekutheleleni okunamandla.